Your browser doesn't support javascript.
loading
E2EFP-MIL: End-to-end and high-generalizability weakly supervised deep convolutional network for lung cancer classification from whole slide image.
Cao, Lei; Wang, Jie; Zhang, Yuanyuan; Rong, Zhiwei; Wang, Meng; Wang, Liuying; Ji, Jianxin; Qian, Youhui; Zhang, Liuchao; Wu, Hao; Song, Jiali; Liu, Zheng; Wang, Wenjie; Li, Shuang; Wang, Peiyu; Xu, Zhenyi; Zhang, Jingyuan; Zhao, Liang; Wang, Hang; Sun, Mengting; Huang, Xing; Yin, Rong; Lu, Yuhong; Liu, Ziqian; Deng, Kui; Wang, Gongwei; Qiu, Mantang; Li, Kang; Wang, Jun; Hou, Yan.
Afiliação
  • Cao L; Department of Biostatistics, School of Public Health, Harbin Medical University, Harbin 150081, China.
  • Wang J; Department of Tumor Biobank, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing 210009, China.
  • Zhang Y; Department of Pathology, Peking University People's Hospital, Beijing 100044, China.
  • Rong Z; Department of Biostatistics, School of Public Health, Peking University, Beijing 100191, China.
  • Wang M; Department of Biostatistics, School of Public Health, Harbin Medical University, Harbin 150081, China.
  • Wang L; Department of Biostatistics, School of Public Health, Harbin Medical University, Harbin 150081, China.
  • Ji J; Department of Biostatistics, School of Public Health, Harbin Medical University, Harbin 150081, China.
  • Qian Y; Department of Thoracic Surgery, The First Affiliated Hospital of Shenzhen University, Shenzhen 518000, China.
  • Zhang L; Department of Biostatistics, School of Public Health, Harbin Medical University, Harbin 150081, China.
  • Wu H; Department of Thoracic Surgery, The First Affiliated Hospital of Shenzhen University, Shenzhen 518000, China.
  • Song J; Department of Biostatistics, School of Public Health, Peking University, Beijing 100191, China.
  • Liu Z; Department of Thoracic Surgery, Peking University People's Hospital, Beijing 100044, China.
  • Wang W; Department of Biostatistics, School of Public Health, Harbin Medical University, Harbin 150081, China.
  • Li S; Department of Biostatistics, School of Public Health, Harbin Medical University, Harbin 150081, China.
  • Wang P; Department of Thoracic Surgery, Peking University People's Hospital, Beijing 100044, China.
  • Xu Z; Department of Biostatistics, School of Public Health, Harbin Medical University, Harbin 150081, China.
  • Zhang J; Department of Pathology, Jiangsu Cancer Hospital, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing 210009, China.
  • Zhao L; Department of Biostatistics, School of Public Health, Harbin Medical University, Harbin 150081, China.
  • Wang H; Department of Tumor Biobank, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing 210009, China.
  • Sun M; Department of Tumor Biobank, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing 210009, China.
  • Huang X; Department of Pathology, Jiangsu Cancer Hospital, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing 210009, China.
  • Yin R; Department of Thoracic Surgery, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Jiangsu Cancer Hospital, Nanjing 210009, China.
  • Lu Y; Department of Biostatistics, School of Public Health, Peking University, Beijing 100191, China.
  • Liu Z; Biostatistics and SAS Programming, Clinical Sciences, Johnson & Johnson Vision Care, Inc., FL 32256, US.
  • Deng K; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt University Medical Center, Nashville, TN 37232, US.
  • Wang G; Department of Pathology, Peking University People's Hospital, Beijing 100044, China.
  • Qiu M; Department of Thoracic Surgery, Peking University People's Hospital, Beijing 100044, China. Electronic address: qiumantang@163.com.
  • Li K; Department of Biostatistics, School of Public Health, Harbin Medical University, Harbin 150081, China. Electronic address: likang@ems.hrbmu.edu.cn.
  • Wang J; Department of Thoracic Surgery, Peking University People's Hospital, Beijing 100044, China. Electronic address: jwangmd@pku.edu.cn.
  • Hou Y; Department of Biostatistics, School of Public Health, Peking University, Beijing 100191, China. Electronic address: houyan@bjmu.edu.cn.
Med Image Anal ; 88: 102837, 2023 08.
Article em En | MEDLINE | ID: mdl-37216736
Efficient and accurate distinction of histopathological subtype of lung cancer is quite critical for the individualized treatment. So far, artificial intelligence techniques have been developed, whose performance yet remained debatable on more heterogenous data, hindering their clinical deployment. Here, we propose an end-to-end, well-generalized and data-efficient weakly supervised deep learning-based method. The method, end-to-end feature pyramid deep multi-instance learning model (E2EFP-MIL), contains an iterative sampling module, a trainable feature pyramid module and a robust feature aggregation module. E2EFP-MIL uses end-to-end learning to extract generalized morphological features automatically and identify discriminative histomorphological patterns. This method is trained with 1007 whole slide images (WSIs) of lung cancer from TCGA, with AUCs of 0.95-0.97 in test sets. We validated E2EFP-MIL in 5 real-world external heterogenous cohorts including nearly 1600 WSIs from both United States and China with AUCs of 0.94-0.97, and found that 100-200 training images are enough to achieve an AUC of >0.9. E2EFP-MIL overperforms multiple state-of-the-art MIL-based methods with high accuracy and low hardware requirements. Excellent and robust results prove generalizability and effectiveness of E2EFP-MIL in clinical practice. Our code is available at https://github.com/raycaohmu/E2EFP-MIL.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Inteligência Artificial / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Med Image Anal Assunto da revista: DIAGNOSTICO POR IMAGEM Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Inteligência Artificial / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Med Image Anal Assunto da revista: DIAGNOSTICO POR IMAGEM Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China